Reproducibility in the assessment of postmenopausal ovaries with transvaginal ultrasound

被引:5
作者
Modugno, F
Weissfeld, JL
Hill, LM
机构
[1] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA
[2] Magee Womens Hosp, Dept Obstet Gynecol & Reprod Sci, Div Ultrasound, Pittsburgh, PA 15213 USA
关键词
transvaginal ultrasound; ovarian cancer screening; training and certification;
D O I
10.1006/gyno.2000.5785
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The goal of this study was to evaluate the exterexaminer variation in the assessment of postmenopausal ovaries using transvaginal ultrasound (TW). Methods. One hundred eighty-eight cancer screening trial participants undergoing TW were reassessed by a second TVU examination. Results. Although first examiners tended to describe significantly larger left (P < 0.001) but smaller right (P = 0.036) ovaries, as well as fewer ovarian abnormalities, examiners agreed on the test interpretation 93% of the time (kappa = 0.846). In only two cases (1%) were the differences in interpretation such that the two examiners recommended different follow-up procedures. Conclusions. Because of the high fatality rate of ovarian cancer, early detection remains the best way to combat this devastating disease. TVU is one screening technique we are currently evaluating in a cancer screening trial. To help ensure screening test reproducibility, we have followed explicit protocols for training and certifying all TW examiners, as well as for conducting TVU examinations. This study demonstrates that by adhering to specific training, certification, and examination protocols, TVU reproducibility is excellent. Such protocols may well serve as a standard for TVU training and examination. (C) 2000 Academic Press.
引用
收藏
页码:289 / 292
页数:4
相关论文
共 11 条
  • [1] *AM CANC SOC, 1999, AM CANC SOC FACTS FI
  • [2] OVARIAN-CANCER SCREENING IN ASYMPTOMATIC POSTMENOPAUSAL WOMEN
    DEPRIEST, PD
    VANNAGELL, JR
    GALLION, HH
    SHENSON, D
    HUNTER, JE
    ANDREWS, SJ
    POWELL, DE
    PAVLIK, EJ
    [J]. GYNECOLOGIC ONCOLOGY, 1993, 51 (02) : 205 - 209
  • [3] Transvaginal sonography as a screening method for the detection of early ovarian cancer
    DePriest, PD
    Gallion, HH
    Pavlik, EJ
    Kryscio, RJ
    vanNagell, JR
    [J]. GYNECOLOGIC ONCOLOGY, 1997, 65 (03) : 408 - 414
  • [4] *FIGO, 1994, ANN REP RES TREATM G, V22
  • [5] Hennekens C.H., 1987, EPIDEMIOLOGY MED
  • [6] INTEROBSERVER VARIATION IN OVARIAN MEASUREMENTS USING TRANSVAGINAL SONOGRAPHY
    HIGGINS, RV
    VANNAGELL, JR
    WOODS, CH
    THOMPSON, EA
    KRYSCIO, RJ
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 39 (01) : 69 - 71
  • [7] Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
    McGuire, WP
    Hoskins, WJ
    Brady, MF
    Kucera, PR
    Partridge, EE
    Look, KY
    ClarkePearson, DL
    Davidson, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (01) : 1 - 6
  • [8] OVARIAN VOLUME IN POSTMENOPAUSAL WOMEN - SUGGESTIONS TO AN OVARIAN SIZE NOMOGRAM FOR MENOPAUSAL AGE
    TEPPER, R
    ZALEL, Y
    MARKOV, S
    COHEN, I
    BEYTH, Y
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1995, 74 (03) : 208 - 211
  • [9] VANNAGELL JR, 1991, CANCER, V68, P679, DOI 10.1002/1097-0142(19910815)68:4<679::AID-CNCR2820680402>3.0.CO
  • [10] 2-J